Renaud D. Heine
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Comparison of Management and Outcomes of Hip Fractures Among Low- and High-Income Patients in Six High-Income Countries.
Journal: Journal of general internal medicine
Published: September 27, 2024
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative.
Journal: Circulation. Cardiovascular quality and outcomes
Published: February 08, 2024
Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: February 08, 2024
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.
Journal: PloS one
Published: July 23, 2023
Variation in care for patients presenting with hip fracture in six high-income countries: A cross-sectional cohort study.
Journal: Journal of the American Geriatrics Society
Published: May 08, 2023
Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
Journal: BMJ (Clinical research ed.)
Published: May 04, 2022
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma.
Journal: Cytotherapy
Published: January 16, 2022
Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe.
Journal: Cancers
Published: June 30, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026